Effect of DNAzymes targeting Akt1 on cell proliferation and apoptosis in nasopharyngeal carcinoma

Cancer Biology and Therapy

Volumn 8, Issue 4, 2009, Pages 366-371

  Yang, Lifang ^a   Xiao, Lanbo ^a   Ma, Xiaoqian ^a   Tang, Min ^a   Weng, Xinxiang ^a   Chen, Xue ^a   Sun, Lunquan ^b   Cao, Ya ^a  

^a Central South University   (China)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Akt1; Anti cancer; Apoptosis; DNAzyme; NPC; Targeting

Indexed keywords

ANTINEOPLASTIC AGENT; DNA; DZ1 ENZYME; DZ2 ENZYME; DZ3 ENZYME; DZ4 ENZYME; DZ5 ENZYME; ENZYME; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; UNCLASSIFIED DRUG;

AKT1 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ELIMINATION; DRUG HALF LIFE; ENZYME INHIBITION; FEMALE; GENE; MOUSE; NASOPHARYNX CANCER; NASOPHARYNX CARCINOMA; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; PROTEIN TARGETING; SEQUENCE ANALYSIS; THERMODYNAMICS; TUMOR XENOGRAFT;

EID: 62549137003     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.4.7433     Document Type: Article

References (20)

1. Shukla S, Maclennan GT, Hartman DJ, Fu P, Resnick MI, Gupta S. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Int J Cancer 2007; 121:1424-32.
2. Ju X, Katiyar S, Wang C, Liu M, Jiao X, Li S, Zhou J, et al. Akt1 governs breast cancer progression in vivo. PNAS 2007; 104:7438-43.
3. Han Z, Hong L, Wu K, Han S, Shen H, Liu C, et al. Reversal of multidrug resistance of gastric cancer cells by downregulation of Akt1 with Akt1 siRNA. J Exp Clin Cancer Res 2006; 25:601-6.
4. Xia C, Meng Q, Cao Z, Shi X, Jiang BH. Regulation of angiogenesis and tumor growth by p110alpha and AKT1 via VEGF expression. J Cell Physiol 2006; 209:56-66.
5. Toker A, Yoeli-Lerner M. Akt signaling and cancer: Surviving but not moving on. Cancer Res 2006; 66:3963-6.
6. Yanagihara M, Katano M, Takahashi-Sasaki N, Taira K, Kimata K, Andoh T. Ribozymes targeting serine/threonine kinase Akt1 sensitize cells to anticancer drugs. Cancer Sci 2005; 96:620-6.
7. Yip WK, Leong VC, Abdullah MA, Yusoff S, Seow HF. Overexpression of phospho-Akt correlates with phosphorylation of EGF receptor, FKHR and BAD in nasopharyngeal carcinoma. Oncol Rep 2008; 19:319-28.
8. Mei YP, Zhou JM, Wang Y, Huang H, Deng R, Feng GK, et al. Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells. Cell Cycle 2007; 6:1379-85.
9. Dass CR, Choong PF, Khachigian LM. DNAzyme technology and cancer therapy: Cleave and let die. Mol Cancer Ther 2008; 7:243-51.
10. Bhindi R, Fahmy RG, Lowe HC, Chesterman CN, Dass CR, Cairns MJ, et al. Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies. Am J Pathol 2007; 171:1079-88.
11. Dass CR. Preclinical anticancer activity of DNA-based cleavage molecules. Drug Dev Ind Pharm 2006; 32:1-5.
12. Zhang G, Dass CR, Sumithran E, Di Girolamo N, Sun LQ, Khachigian LM. Effect of Deoxyribozymes Targeting c-Jun on Solid Tumor Growth and Angiogenesis in Rodents. J Natl Cancer Inst 2004; 96:683-94.
13. Mitchell A, Dass CR, Sun LQ, Khachigian LM. Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1. Nucleic Acids Res 2004; 32:3065-9.
14. Lu ZX, Ma XQ, Yang LF, Wang ZL, Zeng L, Li ZJ, et al. DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma. Cancer Let 2008; 265:226-38.
15. Cairns MJ, Sun LQ. Target-site selection for the 10-23 DNAzyme. Methods Mol Biol 2004; 252:267-77.
16. Yang LF, Zhao Y, Zeng L, Gong JP, Cao Y. hTERT/re-Caspase-3 system induce apoptosis in hTERT-positive cancer cells. Cancer Biol Ther 2006; 11:1546-53.
17. Yamaguchi H, Wang HG. The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 2001; 20:7779-86.
18. Rosner M, Hofer K, Kubista M, Hengstschlager M. Cell size regulation by the human TSC tumor suppressor proteins depends on PI3K and FKBP38. Oncogene 2003; 22:4786-98.
19. Dass CR, Saravolac EG, Li Y, Sun LQ. Cellular uptake, distribution and stability of 10-23 deoxyribozymes. Antisense Nucleic Acid Drug Dev 2002; 12:289-99.
20. Pun SH, Tack F, Bellocq NC, Cheng J, Grubbs BH, Jensen GS, et al. Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particles. Cancer Biol Ther 2004; 3:641-50.